MCID: GLN002
MIFTS: 36

Glanders malady

Categories: Rare diseases, Infectious diseases, Endocrine diseases

Aliases & Classifications for Glanders

About this section

Aliases & Descriptions for Glanders:

Name: Glanders 11 48 2 39 13 68
Infection Due to Pseudomonas Mallei 11
Burkholderia Mallei Infection 48
 
Burkholderia Mallei 48
Farcy Pipes 11

Classifications:



External Ids:

Disease Ontology11 DOID:13444
ICD1030 A24.0
ICD9CM32 024
SNOMED-CT62 35322000, 4639008
MeSH39 D005896
NCIt45 C34638

Summaries for Glanders

About this section
Disease Ontology:11 A primary bacterial infectious disease that results in septicemic infection, has material basis in Burkholderia mallei, which is transmitted by contact with tissues or body fluids of infected animals, or through mucosal surfaces such as the eyes and nose. The infection has symptom fever, has symptom chills, has symptom sweating, has symptom muscle aches, has symptom chest pain, has symptom muscle tightness, has symptom headache, has symptom mucopurulent nasal discharge, and has symptom nodular lesions in the lungs.

MalaCards based summary: Glanders, also known as infection due to pseudomonas mallei, is related to melioidosis and tuberculosis, and has symptoms including fever, chills and sweating. An important gene associated with Glanders is KRT3 (Keratin 3). Affiliated tissues include lung, eye and testes.

CDC:2 Glanders is an infectious disease that is caused by the bacterium Burkholderia mallei. While people can get the disease, glanders is primarily a disease affecting horses. It also affects donkeys and mules and can be naturally contracted by other mammals such as goats, dogs, and cats.

Wikipedia:71 Glanders (from Middle English glaundres or Old French glandres, both meaning glands;Latin: malleus,... more...

Related Diseases for Glanders

About this section

Diseases related to Glanders via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 11)
idRelated DiseaseScoreTop Affiliating Genes
1melioidosis10.9
2tuberculosis9.8
3brucellosis9.7
4q fever9.7
5relapsing fever9.7
6tick-borne relapsing fever9.7
7actinomycosis9.7
8pemphigus9.7
9lymphangitis9.7
10pemphigus vegetans9.7
11corneal argyrosis8.2HCFC1, HSPD1, KRT3, LRP5, PSAP

Graphical network of diseases related to Glanders:



Diseases related to glanders

Symptoms & Phenotypes for Glanders

About this section

Symptoms:

 11 (show all 9)
  • fever
  • chills
  • sweating
  • muscle aches
  • chest pain
  • muscle tightness
  • headache
  • mucopurulent nasal discharge
  • nodular lesions in the lungs

Drugs & Therapeutics for Glanders

About this section

Drugs for Glanders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MelphalanapprovedPhase 1712148-82-34053, 460612
Synonyms:
(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid
(2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid
148-82-3
3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine
3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine
3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine
3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine
3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine
3025 C.B.
3025 c.b
3223-07-2
4-(Bis(2-chloroethyl)amino)-L-phenylalanine
4-14-00-01689 (Beilstein Handbook Reference)
4-[Bis(2-chloroethyl)amino]-L-phenylalanine
4-[Bis-(2-chloroethyl)amino]-L-phenylalanine
AC1LA2OE
ALKERAN (TN)
AY3360000
Alanine Nitrogen Mustard
Alkeran
AmbotzHAA1563
At-290
BIDD:GT0044
BRD-K87827419-001-02-8
BRN 2816456
BSPBio_002407
C13H18Cl2N2O2
CB 3025
CB-3025
CCRIS 374
CHEBI:165415
CHEBI:28876
CHEMBL852
CID460612
D00369
DivK1c_000653
EINECS 205-726-3
HMS2090B09
HMS2091B16
HMS502A15
HSDB 3234
IDI1_000653
KBio1_000653
KBio2_000877
KBio2_003445
KBio2_006013
KBio3_001627
KBioGR_001284
KBioSS_000877
L-3-(P-(Bis(2-chloroethyl)amino)phenyl)alanine
L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine
L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine
L-PAM
L-Phenylalanine mustard
L-Sarcolysin
L-Sarcolysine
L-Sarkolysin
LS-15868
LS-865
 
Levofalan
Levofolan
Levopholan
M2011_SIGMA
MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN))
MLS001333666
MLS002153368
Melfalan
Melfalano
Melfalano [INN-Spanish]
Melphalan (JP15/USP/INN)
Melphalan [USAN:INN:BAN:JAN]
Melphalanum
Melphalanum [INN-Latin]
Mephalan
MolPort-003-665-535
NCGC00090757-01
NCGC00090757-02
NCGC00090757-03
NCI-C04853
NINDS_000653
NIOSH/AY3360000
NSC 241286
NSC 8806
NSC-8806
NSC241286
NSC8806
P-Di-(2-chloroethyl)amino-L-phenylalanine
P-L-Sarcolysin
P-N-Bis(2-chloroethyl)amino-L-phenylalanine
Phenylalanine mustard
Phenylalanine nitrogen mustard
Prestwick_1006
RCRA waste no. U150
Rcra waste number U150
SK-15673
SMP2_000174
SMR000058720
SPBio_000287
SPECTRUM1500382
Sarcolysine
Sarkolysin
Spectrum2_000074
Spectrum3_000684
Spectrum4_000882
Spectrum5_001601
Spectrum_000397
TL8001065
TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN)
TRANSGENIC MODEL EVALUATION (MELPHALAN)
UNII-Q41OR9510P
melphalan
p-Bis(beta-chloroethyl)aminophenylalanine
p-Di-(2-chloroethyl)amino-L-phenylalanine
p-L-Sarcolysin
p-L-sarcolysine
p-N,N-bis(2-chloroethyl)amino-L-phenylalanine
p-N-Bis(2-chloroethyl)amino-L-phenylalanine
p-N-Di(chloroethyl)aminophenylalanine
p-N-di(chloroethyl)aminophenylala nine
phenylalanine nitrogen mu stard
2
MentholapprovedPhase 123532216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
3AnestheticsPhase 19001
4Immunosuppressive AgentsPhase 112770
5Alkylating AgentsPhase 14694
6Antineoplastic Agents, AlkylatingPhase 14474
7
Procaineapproved, investigational, vet_approved4859-46-14914
Synonyms:
.beta.-(Diethylamino)ethyl p-aminobenzoate
.beta.-Diethylaminoethyl 4-aminobenzoate
2-(Diethylamino)ethyl 4-aminobenzoate
2-(Diethylamino)ethyl p-aminobenzoate
2-(Diethylamino)ethyl-4-aminobenzoate
2-Diethylaminoethyl 4-aminobenzoate
2-Diethylaminoethyl p-aminobenzoate
2-Diethylaminoethylester kyseliny p-aminobenzoove
2-Diethylaminoethylester kyseliny p-aminobenzoove [Czech]
4-14-00-01138 (Beilstein Handbook Reference)
4-Aminobenzoesaeure-beta-diethylaminoethylester
4-Aminobenzoic acid 2-(diethylamino) ethyl ester
4-Aminobenzoic acid diethylaminoethyl ester
4-aminobenzoic acid 2-diethylaminoethyl ester
59-46-1
91484-72-9
AB00053531
AC1L1J8C
AC1Q2ZE2
AKOS000115407
Allocaine
Anticort
Anticort (TM)
Anuject
BENZOIC ACID,4-AMINO,2-DIETHYLAMINOETHYL ESTER PROCAIN BASE
BPBio1_000179
BRD-K24616672-003-05-2
BRN 0913480
BSPBio_000161
BSPBio_002231
Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester
Benzoic acid, p-amino-, 2-(diethylamino)ethyl ester
C07375
CAS-51-05-8
CHEBI:8430
CHEMBL569
CID4914
D08422
DB00721
Diethylaminoethyl p-aminobenzoate
DivK1c_000120
Duracaine
EINECS 200-426-9
Factor H3
Gerokit
Gerovital
Gerovital H-3
HSDB 3388
I06-1439
IDI1_000120
InChI=1/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H
Jenacain
Jenacaine
KBio1_000120
KBio2_001318
KBio2_003886
KBio2_006454
KBio3_001731
 
KBioGR_000975
KBioSS_001318
LS-35778
Lopac-P-9879
Lopac0_000966
MolPort-000-889-177
NCGC00015864-01
NCGC00015864-02
NCGC00015864-04
NCGC00162298-01
NINDS_000120
NSC 169497
NSC169497
Nissocaine
Norocaine
Novocain
Novocaine
Prestwick0_000041
Prestwick1_000041
Prestwick2_000041
Prestwick3_000041
Procain
Procaina
Procaina [INN-Spanish]
Procaine (INN)
Procaine HCl
Procaine [INN:BAN]
Procaine, base
Procainum
Procainum [INN-Latin]
SP-01A
SP01
SP01A
SPBio_001331
SPBio_002082
STK177303
STOCK2S-12721
Scurocaine
Solution of novocain
Solution of novocain (TN)
Spectrum2_001296
Spectrum3_000556
Spectrum4_000488
Spectrum5_001186
Spectrum_000838
Spinocaine
Stoff H3
UNII-4Z8Y51M438
Vitamin H3
WLN: ZR DVO2N2&2
beta-(Diethylamino)ethyl 4-aminobenzoate
beta-(Diethylamino)ethyl p-aminobenzoate
beta-Diethylaminoethyl 4-aminobenzoate
p-Aminobenzoic acid 2-diethylaminoethyl ester
p-Aminobenzoyldiethylaminoethanol
p-Aminobenzyoyldiethylaminoethanol
procaine
╬▓-(diethylamino)ethyl 4-aminobenzoate
╬▓-(diethylamino)ethyl p-aminobenzoate
8
Chloroprocaineapproved18133-16-48612
Synonyms:
133-16-4
2-(Diethylamino)ethyl 4-amino-2-chlorobenzoate
2-(Diethylaminoethyl)-4-amino-2-chlorobenzoate
2-Chloroprocaine
2-diethylaminoethyl 4-amino-2-chlorobenzoate
3858-89-7 (hydrochloride)
4-14-00-01273 (Beilstein Handbook Reference)
4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester
4-amino-2-chlorobenzoic acid 2-(diethylamino)ethyl ester
AC1L1RCM
BRN 2808071
Benzoic acid, 4-amino-2-chloro-, 2-(diethylamino)ethyl ester
C07877
C13H19ClN2O2
CHEBI:3636
CHLOROPROCAINE
CID8612
Chlor-procaine
Chloroprocain
 
Chloroprocaine
Chloroprocaine (INN)
Chloroprocaine [INN]
Chloroprocaine hydrochloride
Chloroprocainum
Chloroprocainum [INN-Latin]
Chlorprocaine
Chlorprocainum
Cloroprocaina
Cloroprocaina [INN-Spanish]
D07678
DB01161
HSDB 3301
Halestyn
LS-35706
Nesacaine
Nesacaine MPF
Nesacaine-Ce
Piocaine
UNII-5YVB0POT2H
9Anti-Inflammatory Agents10355
10Anti-Inflammatory Agents, Non-Steroidal4295
11Antirheumatic Agents10627
12Central Nervous System Depressants12806
13Analgesics, Non-Narcotic6260
14Peripheral Nervous System Agents22776
15Anesthetics, Local3272
16Analgesics11287
17
Imidacloprid166105827-78-986418
Synonyms:
(e)-imidacloprid
(z)-imidacloprid
1-((6-Chloro-3-pyridyl)methyl)-N-nitro-2-imidazolidinimine
1-(2-Chloro-5-pyridylmethyl)-2-(nitroimino)imidazolidine
1-[(6-Chloro-3-pyridinyl)methyl]-4,5-dihydro-N-nitro-1H-imidazol-2-amine, 9CI
Admire
Advantage
Advantage flea adulticide
Bayer brand of imidacloprid
 
Confidor
Confidor 200 SL
Confidor SL
Gaucho
Imidacloprid (old RN)
Imidacloprid [iso]
Merit
Merit (insecticide)
Premise 75
Provado

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)CompletedNCT01592955Phase 4
2Spinal Magnetic Stimulation in Neuropathic PainCompletedNCT00443469Phase 3
3Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal MetastasesRecruitingNCT03028337Phase 2
4Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)Not yet recruitingNCT02591901Phase 2
5Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic RadiosurgeryRecruitingNCT02278744Phase 1
6Intra-arterial Chemotherapy for Spinal MetastasesRecruitingNCT01637766Phase 1
7Evaluation of Minimally Invasive Microdiscectomy Versus Conventional Open Microdiscectomy For Lumbar Herniated DiscUnknown statusNCT00927056
8Peristeen Bowel Irrigation System in Cauda EquinaCompletedNCT01784328
9Observational Prospective Study on 2-chloroprocaine Hydrochloride 1% Safety in Intrathecal AnaesthesiaCompletedNCT02067806
10The Effect of Spinal Flexion in the Lateral Decubitus Position on the Unilaterality During Spinal AnesthesiaCompletedNCT01321684
11Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical DeviceCompletedNCT01338467
12Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in FranceCompletedNCT01211652
13Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast CancerRecruitingNCT02740491
14Post-void Bladder Scanning in Acute Cauda Equina SyndromeNot yet recruitingNCT02806167

Search NIH Clinical Center for Glanders


Cochrane evidence based reviews: glanders

Genetic Tests for Glanders

About this section

Anatomical Context for Glanders

About this section

MalaCards organs/tissues related to Glanders:

36
Lung, Eye, Testes, Spleen, Bone, Liver

Publications for Glanders

About this section

Articles related to Glanders:

(show top 50)    (show all 133)
idTitleAuthorsYear
1
Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice. (26955620)
2016
2
Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches. (27010618)
2016
3
Glanders and history. (27339929)
2016
4
Harmonising diagnostic testing for glanders in equids. (27313253)
2016
5
Interlaboratory ring trial to evaluate CFT proficiency of European laboratories for diagnosis of glanders in equines. (27122499)
2016
6
Burkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders. (27271739)
2016
7
Glanders and the risk for its introduction through the international movement of horses. (27288893)
2016
8
Surveillance focus: glanders. (26183359)
2015
9
Efficacy of Postexposure Therapy against Glanders in Mice. (25645854)
2015
10
Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders. (26148026)
2015
11
Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine. (25533326)
2015
12
Pathological findings and diagnostic implications of a rhesus macaque (Macacca mulatta) model of aerosol-exposure to Burkholderia mallei (glanders). (25850696)
2015
13
From glanders to globulins: A study in comparative medicine. (26307410)
2015
14
Optimization and validation of indirect ELISA using truncated TssB protein for the serodiagnosis of glanders amongst equines. (24672321)
2014
15
Effect of incubation temperature on the diagnostic sensitivity of the glanders complement fixation test. (25812210)
2014
16
Genotyping of Burkholderia mallei from an outbreak of glanders in Bahrain suggests multiple introduction events. (25255232)
2014
17
Comparative experimental subcutaneous glanders and melioidosis in the common marmoset (Callithrix jacchus). (25477002)
2014
18
Assessment of the effectiveness of the PPD-mallein produced in Brazil for diagnosing glanders in mules. (24159303)
2013
19
Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders. (23517714)
2013
20
Glanders: an overview of infection in humans. (24004906)
2013
21
From glanders to Hendra virus: 125 years of equine infectious diseases. (23997164)
2013
22
Glanders in animals: a review on epidemiology, clinical presentation, diagnosis and countermeasures. (22630609)
2013
23
Glanders outbreak at Tehran Zoo, Iran. (22783454)
2012
24
Evaluation of recombinant proteins of Burkholderia mallei for serodiagnosis of glanders. (22695165)
2012
25
Humoral immune responses in a human case of glanders. (22398248)
2012
26
Development of hydrolysis probe-based real-time PCR for identification of virulent gene targets of Burkholderia pseudomallei and B. mallei--a retrospective study on archival cases of service members with melioidosis and glanders. (22360070)
2012
27
Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. (22912938)
2012
28
Development and validation of a method for purification of mallein for the diagnosis of glanders in equines. (22937975)
2012
29
Performance of complement fixation test and confirmatory immunoblot as two-cascade testing approach for serodiagnosis of glanders in an endemic region of South East Asia. (22515029)
2012
30
Recent progress in melioidosis and glanders. (22529846)
2012
31
Development of novel O-polysaccharide based glycoconjugates for immunization against glanders. (23205347)
2012
32
Emergence and re-emergence of glanders in India: a description of outbreaks from 2006 to 2011. (22718333)
2012
33
Effectiveness of an antimicrobial treatment scheme in a confined glanders outbreak. (23134717)
2012
34
Protective antigens against glanders identified by expression library immunization. (22125550)
2011
35
Comparative evaluation of three commercially available complement fixation test antigens for the diagnosis of glanders. (21896565)
2011
36
Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders. (21752949)
2011
37
Diagnostic assays for glanders. (22184353)
2011
38
Use of a Western blot technique for the serodiagnosis of glanders. (21247488)
2011
39
Re-emergence of glanders in India - Report of Maharashtra state. (23100851)
2010
40
Present and future therapeutic strategies for melioidosis and glanders. (20192686)
2010
41
Glanders in donkeys (Equus Asinus) in the state of pernambuco, Brazil: A case report. (24031474)
2010
42
Molecular epidemiology of glanders, Pakistan. (19961695)
2009
43
Prevalence-dependent use of serological tests for diagnosing glanders in horses. (19723336)
2009
44
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. (19490962)
2009
45
Glanders. (18710311)
2008
46
Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice. (17908615)
2007
47
Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis. (17362501)
2007
48
Glanders: off to the races with Burkholderia mallei. (18031330)
2007
49
Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis. (18221181)
2007
50
Comparative evaluation of Rose Bengal plate agglutination test, mallein test, and some conventional serological tests for diagnosis of equine glanders. (17609344)
2007

Variations for Glanders

About this section

Expression for genes affiliated with Glanders

About this section
Search GEO for disease gene expression data for Glanders.

Pathways for genes affiliated with Glanders

About this section

GO Terms for genes affiliated with Glanders

About this section

Cellular components related to Glanders according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mitochondrionGO:00057398.0HCFC1, HSPD1, LRP5, PSAP

Biological processes related to Glanders according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein stabilizationGO:00508219.4HCFC1, HSPD1

Sources for Glanders

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet